OJVM  Vol.3 No.1 , March 2013
Factors Influencing Serum Amyloid Type A (Saa) Concentrations in Horses
Abstract: The acute phase response (APR) is the reaction that occurs in animals in response to disturbances in hemostasis following tissue damage. In horses, the APR is manifested in a variety of pathological processes of various origins, such as infections caused by bacteria, viruses, parasites, arthritis, burns, chemicals, trauma surgery and stress. Acute phase proteins (APPs) are considered those proteins that modify its plasma concentration at least 25% in inflammatory and infectious processes. In adult horses, various respiratory inflammatory processes, gastrointestinal tract, reproductive organs and musculoskeletal system are accompanied by increased levels of a specific APP, so-called serum amyloid type A (SAA). SAA is the most important major APP in the horse. This paper provides a review of physiological factors affecting SAA levels and their role in horses in defense of natural mechanisms, the pathways involved and their material components.
Cite this paper: K. Satué, A. Calvo and J. Gardón, "Factors Influencing Serum Amyloid Type A (Saa) Concentrations in Horses," Open Journal of Veterinary Medicine, Vol. 3 No. 1, 2013, pp. 58-66. doi: 10.4236/ojvm.2013.31010.

[1]   E. Gruys, M. J. M. Toussaint, W. J. M. Landman, M. Tivapasi, R. Chamanza and L. Van Veen, “Infection, Inflammation and Stress Inhibit Growth. Mechanisms and Non-Specific Assessment of the Processes by Acute Phase Proteins,” In: T. Wensing, Ed., Production Diseases in Farm Animals, Wageningen Press, Wageningen, 1999, pp. 72-87.

[2]   P. D. Eckersall, “Recent Advances and Future Prospects for the Use of Acute Phase Proteins as Markers of Disease in Animals,” Revue de Medicine Veterinary, Vol. 151, No. 7, 2000, pp. 577-578.

[3]   J. J. Ceron, P. D. Eckersall and S. Martynez-Subiela, “Acute Phase Proteins in Dogs and Cats: Current Knowledge and Future Perspectives,” Veterinary Clinical Pathology, Vol. 34, No. 2, 2005, pp. 85-99. doi:10.1111/j.1939-165X.2005.tb00019.x

[4]   M. V. Crisman, W. K. Scarratt and K. L. Zimmerman, “Blood Proteins and Inflamationin the Horse,” Veterinary Clinics of North America: Equine Practice, Vol. 24, No. 2, 2008, pp. 285-297. doi:10.1016/j.cveq.2008.03.004

[5]   S. Casella, F. Fazio, C. Giannetto, E. Giudice and G. Piccione, “Influence of Transportation on Serum Concentrations of Acute Phase Proteins in Horse,” Research Veterinary Science, Vol. 93, No. 2, 2012, pp. 914-917. doi:10.1016/j.rvsc.2012.01.004

[6]   A. Cywinska, R. Gorecka, E. Szarska, L. Witkowki, P. Dziekan and A. Scholienberger, “Serum Amyloid A Level as a Potential Indicator of the Status of Endurance Horses,” Equine Veterinary Journal, Vol. 42, No. S38, 2010, pp. 23-27. doi:10.1111/j.2042-3306.2010.00280.x

[7]   A. Cywińska, E. Szarska, R. Górecka, L. Witkowski, M. Hecold, A. Bereznowski, A. Schollenberger and A. Winnicka, “Acute Phase Protein Concentrations after Limited Distance and Long Distance Endurance Rides in Horses,” Research Veterinary Science, Vol. 93, No. 3, 2012, pp. 1402-1406. doi:10.1016/j.rvsc.2012.02.008

[8]   J. Kent, “Acute Phase Proteins: Their Use in Veterinary Diagnosis,” British Veterinary Journal, Vol. 148, No. 4, 1992, pp. 279-282. doi:10.1016/0007-1935(92)90081-B

[9]   D. Thompson, A. Mildford-Ward and J. Whicher, “The Value of Acute Phase Measurements in Clinical Practice,” Annals of Clinical Biochemistry, Vol. 29, No. 2, 1992, pp. 123-131.

[10]   I. Kushner and A. Mackiewicz, “The Acute Phase Response: An Overview,” In: A. Mackiewicz, I. Kushner, H. Baumann, Eds., Acute Phase Proteins Molecular Biology, Biochemistry and Clinical Applications, CRC Press, Boca Ratón, 1993, pp. 3-19.

[11]   A. Hillstr?m, H. Tvedten and I. Lilieh??k, “Evaluation of an In-Clinic Serum Amyloid A (SAA) Assay and Assessment of the Effects of Storage on SAA Samples,” Acta Veterinaria Scandinavica, Vol. 2, No. 1, 2010, pp. 52-58.

[12]   C. Gabay and I. Kushner, “Acute Phase Proteins and Other Systemic Responses to Inflammation,” New England Journal of Medicine, Vol. 340, 1999, pp. 448-454. doi:10.1056/NEJM199902113400607

[13]   S. Jacobsen and P. H. Andersen, “The Acute Phase Protein Serum Amyloid A (SAA) as a Marker of Inflammation in Horses,” Scandinavian Journal of Immunology Vol. 19, No. 1, 2007, pp. 38-46.

[14]   A. Husebekk, G. Husby, K. Sletten, G. Marhaug and K. Nordstoga, “Characterization of Amyloid Protein AA and Its Serum Precursor SAA in the Horse,” Scandinavian Journal of Immunology, Vol. 23, No. 6, 1986, pp. 703- 709. doi:10.1111/j.1365-3083.1986.tb02007.x

[15]   Y. Nunokawa, T. Fujinaga, T. Taira, M. Okumura, K. Yamashita, N. Tsunoda and M. Hagio, “Evaluation of Serum Amyloid A Protein as an Acute-Phase Reactive Protein in Horses,” Journal of Veterinary Medical Science, Vol. 55, No. 6, 1993, pp. 1011-1016. doi:10.1292/jvms.55.1011

[16]   K. Sletten, A. Husebekk and G. Husby, “The Primary Structure of Equine Serum Amyloid A (SAA) Protein,” Scandinavian Journal of Immunology, Vol. 30, No. 1, 1989, pp. 117-122. doi:10.1111/j.1365-3083.1989.tb01195.x

[17]   C. Hultén, K. Sletten, C. F. Bruun and G. Marhaug, “The Acute Phase Serum Amyloid A Protein (SAA) in the Horse: Isolation and Characterization of Three Isoforms,” Veterinary Immunology Immunopathology, Vol. 57, No. 3-4, 1999, pp. 215-227. doi:10.1016/S0165-2427(97)00021-4

[18]   S. Jacobsen, Th. A. Niewold, M. H. Thomsen, S. Nanni, C. Lindegaard, E. Olsen and P. H. Andersen, “Serum Amyloid A Isoforms in Serum and Synovial Fluid in Horses with Lipopolysaccharide-Induced Arthritis,” Veterinary Immunology Immunopathology, Vol. 112, No. 3-4, 2006, pp. 321-322. doi:10.1016/j.vetimm.2005.10.014

[19]   L. C. Berg, S. Jacobsen and P. D. Thomsen, “Local Production of Serum Amyloid A in Equine Articular Cartilage and Cultured Chondrocytes,” International Journal of Experimental Pathology, Vol. 88, No. 4, 2007, pp. 58- 59.

[20]   L. C. Berg, P. D. Thomsen, P. H. Andersen, H. E. Jensen and S. Jacobsen, “Serum Amyloid A Is Expressed in Histologically Normal Tissues from Horses and Cattle,” Veterinary Immunology and Immunopathology, Vol. 144, No. 1-2, 2011, pp. 155-159. doi:10.1016/j.vetimm.2011.06.037

[21]   T. L. McDonald, M. A. Larson, D. R. Mack and A. Weber, “Elevated Extrahepatic Expression and Secretion of Mammary-Associated Serum Amyloid A 3 (M-SAA3) into Colostrum,” Veterinary Immunology Immunopathology, Vol. 83, No. 3-4, 2001, pp. 203-211. doi:10.1016/S0165-2427(01)00380-4

[22]   S. Jacobsen, M. H. Thomsen and S. Nanni, “Concentrations of Serum Amyloid A in Serum and Synovial Fluid from Healthy Horses and Horses with Joint Disease,” American Journal of Veterinary Research, Vol. 67, No. 10, 2006, pp. 1738-1742. doi:10.2460/ajvr.67.10.1738

[23]   C. Hultén, R. M. Tulamo, M. M. Suominem, K. Burwall, G. Marhaug and M. Forsberg, “A Non-Competitive Chemiluminescence Enzyme Immunoassay for the Equine Acute Phase Protein Serum Amyloid A (SAA)—A Clinically Useful Inflammatory Marker in the Horse,” Veterinary Immunology Immunopathology, Vol. 68, No. 2-4, 1999, pp. 267-281. doi:10.1016/S0165-2427(99)00027-6

[24]   S. J. Stoneham, L. Palmer, R. Cash and P. D. Rossdale, “Measurement of Serum Amyloid A in the Neonatal Foal Using a Latex Agglutination Immunoturbidimetic Assay: Determination of the Normal Range, Variation with Age and Response to Disease,” Equine Veterinary Journal, Vol. 33, 2001, pp. 559-603.

[25]   K. Satué and A. Calvo, “Normal Values of Serum Amyloid A, Haptoglobin and C-Reactive Protein in Spanish Purebred Mares during Estrous Cycle,” Proceeding of the 16th Italian Association of Equine Veterinarians Congress, Carrara, 29-31 January 2010, p. 263.

[26]   K. Satué, A. Calvo and P. Montesinos, “Normal Values of Serum Amyloid A, Haptoglobin and C-Reactive Protein in Spanish Purebred Mares during Pregnancy,” Proceeding of the 12th International Congress of European College of Veterinary Internal Medicine, Dublin, 1-3 September 2010, p. 549.

[27]   K. Satué, A. Calvo and J. J. Cerón, “Proteínas de Fase Aguda: Pueden ser Utilizadas Como Fuente de Diagnóstico de Gestación en la Yegua Pura Raza Espa?ola?” Proceeding of the 10th International Congress of Medicine and Surgery Equine, Sevilla, 27-28 November 2010, pp. 141-144.

[28]   C. Hultén, B. Sandgren, E. Ski?ldebrand, B. Kligeborn, G. Marhaug and M. Forsberg, “The Acute Phase Protein Serum Amyloid A (SAA) as an Inflammatory Marker in Equine Influenza Virus Infection,” Acta Veterinaria Scandinavica, Vol. 40, No. 4, 1999, pp. 323-333.

[29]   C. Hultén and S. Demmers, “Serum Amyloid A (SAA) as an Aid in the Management of Infectious Disease in the Foal: Comparison with Total Leucocyte Count, Neutrophil Count and Fibrinogen,” Equine Veterinary Journal, Vol. 34, No. 7, 2002, pp. 693-698. doi:10.2746/042516402776250360

[30]   C. Hultén, U. Gr?nlund, J. Hirvonen, R. M. Tulamo, M. M. Suominem, G. Marhaug and M. Forsberg, “Dynamics in the Serum of the Inflammatory Markers Serum Amyloid A (SAA), Haptoglobin, Fibrinogen and ?2-Globulins during Induced Non-Infectious Arthritis in the Horse,” Equine Veterinary Journal, Vol. 34, No. 7, 2002, pp. 669- 704.

[31]   S. Jacobsen, J. C. Jensen, S. Frei, A. L. Jensen and M. B. Thoefner, “Use of Serum Amyloid A and Other Acute Phase Reactants to Monitor the Inflammatory Response after Castration in Horses: A Field Study,” Equine Veterinary Journal, Vol. 37, No. 6, 2005, pp. 552-556. doi:10.2746/042516405775314853

[32]   S. Jacobsen, J. V. Nielsen, M. Kjelgaard-Hansen, T. Toelboell and J. Fjeldborg, “Acute Phase Response to Surgery of Varying Intensity in Horses: A Preliminary Study,” Veterinary Surgery, Vol. 38, No. 6, 2009, pp. 762-769. doi:10.1111/j.1532-950X.2009.00564.x

[33]   P. J. Pollock, M. Prendergast, J. Schumacher and C. R. Bellenger, “Effects of Surgery on the Acute Response in Clinically Normal and Diseased Horses,” Veterinary Record, Vol. 156, No. 17, 2005, pp. 538-542.

[34]   M. B. Pepys, M. L. Baltz and G. A. Tennent, “Serum Amyloid A protein (SAA) in Horses: Objective Measurement of the Acute Phase Response,” Equine Veterinary Journal, Vol. 21, No. 2, 1989, pp. 106-109. doi:10.1111/j.2042-3306.1989.tb02108.x

[35]   M. Christensen, S. Jacobsen, T. Ichiyanagi and M. Kjelgaard-Hansen, “Evaluation of an Automated Assay Base Don Monoclonal Anti-Human Serum Amyloid A (SAA) Antibodies for Measurement of Canine, Feline and Equine SAA,” Veterinary Journal, Vol. 194, No. 3, 2012, pp. 332-337. doi:10.1016/j.tvjl.2012.05.007

[36]   M. Satoh, T. Fujinaga, M. Okumura and M. Hagio, “Sándwich Enzyme-Linked Immunosorbent Assay for Quantitative Measurement of Serum Amyloid A Protein in Horses,” American Journal of Veterinary Research, Vol. 56, Vol. 10, 1995, pp. 1286-1291.

[37]   V. Duggan, G. R. Holyoak, C. G. Mac Allister and A. W. Confer, “Influence of Induction of Parturition on the Neonatal Acute Phase Response in Foals,” Theriogenology, Vol. 67, No. 2, 2007, pp. 372-381. doi:10.1016/j.theriogenology.2006.06.015

[38]   S. Paltrinieri, “The Feline Acute Phase Reaction,” Veterinary Journal, Vol. 177, No. 1, 2008, pp. 26-35. doi:10.1016/j.tvjl.2007.06.005

[39]   E. Harada, Y. Araki, E. Furumura, T. Takeuchi, K. Sitizyo, T. Yajima and T. Kuwata, “Characteristic Transfer of Colostrum-Derived Biologically Active Substances into Cerebrospinal Fluid via Blood in Natural Suckling Neonatal Pigs,” Journal of Veterinary Medicine A Physiology, Pathology, Clinical Medicine, Vol. 49, No. 7, 2002, pp. 358-364. doi:10.1046/j.1439-0442.2002.00457.x

[40]   P. M. Chavatte, M. B. Pepys, B. Roberts, J. C. Ousey, A. J. McGladdery and P. D. Rossdale, “Measurement of Serum Amyloid A protein (SAA) as an Aid to Differential Diagnosis of Infection in Newborn Foals,” In: W. Plowright, P. D. Rossdale, J. F. Wade and J. F. Eds., Equine Infectious Diseases 6, Proceedings of the 6th International Conference, R&W Publications, Newmarket, 1992, pp. 33-38.

[41]   C. J. Rosenthal and E. C. Franklin, “Variation with Age and Disease of an Amyloid A Protein-Related Serum Component,” Journal of Clinical Investigation, Vol. 55, No. 4, 1975, pp. 746-753. doi:10.1172/JCI107985

[42]   M. Chistoffersen, C. Baagore, S. Jacobsen, A. M. Bojesen, M. R. Petersen and H. Lehn-Jensen, “Evaluation of the Systemic Acute Phase Response and Endometrial Gene Expression of Serum Amyloid A and Pro- and Anti-Inflammatory Cytokines in Mares with Experimentally Induced Endometritis,” Veterinary Immunology and Immunopathology, Vol. 138, No. 1-2, 2010, pp. 95-105. doi:10.1016/j.vetimm.2010.07.011

[43]   M. Christoffersen, E. Woodward, A. M. Bojesen, S. Jacobsen, M. R. Petersen, M. H. Troedsson and H. Lehn-Jensen, “Inflammatory Responses to Induced Infectious Endometritis in Mares Resistant or Susceptible to Persistent Endometritis,” BMC Veterinary Research, Vol. 29, No. 8, 2012, p. 41. doi:10.1186/1746-6148-8-41

[44]   R. Dabrowski, K. Kostro, U. Lisiecka, M. Szczubia? and L. Krakowski, “Usefulness of C-Reactive Protein, Serum Amyloid A Component, and Haptoglobin Determinations in Bitches with Pyometra for Monitoring Early Post- Ovariohysterectomy Complications,” Theriogenology, Vol. 72, No. 4, 2009, pp. 471-476. doi:10.1016/j.theriogenology.2009.03.017

[45]   F. Tecles, M. Caldín, A. Zanella, F. Membiela, A. Tvarijonaviciute, S. Martínez Subiela and J. J. Cerón, “Serum Acute Phase Protein Concentrations in Female Dogs with Mammary Tumors,” Journal of Veterinary Diagnostic Investigation, Vol. 21, No. 2, 2009, pp. 214-219. doi:10.1177/104063870902100206

[46]   L. Krakowski, C. H. Krawcyk, K. Kostro, T. Stefaniak, F. Novotry and J. Obara, “Serum Levels of Acute Phase Proteins: SAA, Hp and Progesterone (P4) in Mares with Early Embryonic Death,” Reproduction in Domestic Animals, Vol. 46, No. 4, 2011, pp. 624-629. doi:10.1111/j.1439-0531.2010.01715.x

[47]   V. Duggan, “Serum Amyloid A in the Neonatal Foal: The Significance of Peri-Parturient Events,” Veterinary Journal, Vol. 176, No. 3, 2008, pp. 267-269. doi:10.1016/j.tvjl.2007.08.029

[48]   M. A. Larson, S. H. Wei, A. Weber, A. T. Weber and T. L. McDonald, “Induction of Human Mammary-Associated Serum Amyloid A3 Expression by Prolactin or Lipopolysaccharide,” Biochemical and Biophysical Research Communications, Vol. 301, No. 4, 2003, pp. 1030-1037. doi:10.1016/S0006-291X(03)00045-7

[49]   D. R. Mack, T. L. McDonald, M. A. Larson, S. Wei and A. Weber, “The Conserved TFLK Motif of Mammary- Associated Serum Amyloid A3 Is Responsible for Up- Regulation of Intestinal MUC3 Mucin Expression in Vitro,” Pediatric Research, Vol. 53, 2003, pp. 137-142. doi:10.1203/00006450-200301000-00023

[50]   A. J. Molenaar, D. P. Harris, G. H. Rajan, M. L. Pearson, M. R. Callaghan, L. Sommer, V. C. Farr, K. E. Oden, M. C. Miles, R. S. Petrova, L. L. Good, K. Singh, R. D. McLaren, C. G. Prosser, K. S. Kim, R. J. Wieliczko, M. H. Dines, K. M. Johannessen, M. R. Grigor, S. R. Davis and K. Stelwagen, “The Acute-Phase Protein Serum Amyloid A3 Is Expressed in the Bovine Mammary Gland and Plays a Role in Host Defense,” Biomarkers, Vol. 14, No. 1, 2009, pp. 26-37. doi:10.1080/13547500902730714

[51]   K. Baintner and J. Csapó, “Lack of Acid-Resistant Trypsin Inhibitor in Mare’s Colostrum: Short Communication,” Acta Veterinaria Hungarica, Vol. 44, No. 1, 1996, pp. 95-97.

[52]   G. P. Sacks, K. Studena, I. L. Sargent and W. G. Redman, “Normal Pregnancy and Pre-Clampsia Both Produce Inflammatory Changes in Peripheral Blood Leukocytes Akin to Those of Sepsis,” American Journal of Obstetrics & Gynecology, Vol. 179, No. 1, 1988, pp. 80-86. doi:10.1016/S0002-9378(98)70254-6

[53]   M. D. Savvidou, C. C. Lees, M. Parra, A. D. Hingorani and K. H. Nicolaides, “Levels of C-Reactive Protein in Pregnant Women Who Subsequently Develop Pre-Clampsia,” BJOG, Vol. 109, No. 3, 2002, pp. 297-301. doi:10.1111/j.1471-0528.2002.01130.x

[54]   A. F. Sanchez Teran, L. M. Rubio-Martinez, N. F. Villarino and M. G. Sanz, “Effects of Repeated Intra-Articular Administration of Amikacin on Serum Amyloid A, Total Protein and Nucleated Cell Count in Sinovial Fluid from Healthy Horses,” Equine Veterinary Journal, Vol. 44, No. S43, 2012, pp. 12-16. doi:10.1111/j.2042-3306.2012.00637.x

[55]   M. Henriksen, S. Jacobsen and P. H. Andersen, “Serum Amyloid A (SAA) in Equine Serum and Vitreous,” Veterinary Ophthalmology, Vol. 12, No. 1, 2009, pp. 6-7.

[56]   A. L. Labelle, R. E. Hamor, A. L. Macneill, K. M. Lascola, C. B. Breaux and E. L. Tolar, “Effects of Ophthalmic Disease on Concentrations of Plasma Fibrinogen and Serum Amyloid A in the Horse,” Equine Veterinary Journal, Vol. 43, No. 4, 2011, pp. 460-465. doi:10.1111/j.2042-3306.2010.00305.x

[57]   K. Tsukada, S. Takenoshita and Y. Nagamachi, “Peritoneal Interleukin-6, Interleukin-8, and Granulocyte Elastase Activity after Elective Abdominal Surgery,” APMIS, Vol. 102, No. 7-12, 1994, pp. 837-840. doi:10.1111/j.1699-0463.1994.tb05242.x

[58]   N. E. Robinson, “Recurrent Airway Obstruction (Heaves),” In: P. Lekeux, Ed., Equine Respiratory Diseases, International Veterinary Information Service, Ithaca, New York, 2001.

[59]   A. Lavoie-Lamoureux, M. Leclere, K. Lemos, B. Wagner and J. P. Lavoie, “Markers of Systemic Inflammation in Horses with Heaves,” Journal Veterinary Internal Medicine, Vol. 26, No. 6, 2012, pp. 1419-1426. doi:10.1111/j.1939-1676.2012.00993.x

[60]   N. D. Cohen, M. K. Chaffin, M. L. Vandenplas, R. F. Edwards, M. Nevill, J. N. Moore and R. J. Martens, “Study of Serum Amyloid A Concentrations as a Means of Achieving Early Diagnosis of Rhodococcus equi Pneumonia,” Equine Veterinary Journal, Vol. 37, No. 3, 2005, pp. 212-216. doi:10.2746/0425164054530704

[61]   H. H. Petersen, J. P. Nielsen, C. Helweg and P. M. Heeg?rd, “Application of Acute Phase Protein Measurements in Veterinary Clinical Chemistry,” Veterinary Research, Vol. 35, No. 2, 2004, pp. 163-187. doi:10.1051/vetres:2004002

[62]   S. A. Andersen, H. H. Petersen, A. K. Ersboll, J. Falk-Ronne, A. L. Jensen and S. Jacobsen, “Equine Serum Amyloid A Response Following Vaccination against Influenza and Tetanus,” Proceeding of International Colloquium on Acute Phase Proteins, Dublin, 14-15 March 2005, p. 36.

[63]   S. A. Andersen, H. H. Petersen, A. K. Ersboll, J. Falk- Ronne, A. L. Jensen and S. Jacobsen, “Vaccination Elicits a Prominent Acute Phase Response in Horses,” Veterinary Journal, Vol. 121, No. 2, 2012, pp. 199-202. doi:10.1016/j.tvjl.2011.01.019

[64]   E. Wattrang, D. M. Jesset, P. Yates, L. Fuxler and D. Hannant, “Experimental Infection of Ponies with Equine Influenza A2 (H3N8) Virus Strains of Different Pathogenicity Elicits Varying Interferon and Interlukin-6 Responses,” Viral Immunology, Vol. 16, No. 1, 2003, pp. 57-67. doi:10.1089/088282403763635456

[65]   J. Danek, “Level of Interlukin-1β and Clinical Signs after Endotoxin Injection in Stallions,” Bulletin of the Veterinary Institute Pulawy, Vol. 46, 2002, pp. 179-185.

[66]   M. B. Pepys, “C-Reactive Protein Fifty Years on,” Lancet, Vol. 317, No. 8221, 1981, pp. 653-857. doi:10.1016/S0140-6736(81)91565-8

[67]   J. T. Whicher and P. Dieppe, “Acute Phase Proteins,” Journal of Allergy and Clinical Immunology, Vol. 5, 1985, pp. 425-446.

[68]   G. Husby, “Equine Amyloidosis,” Equine Veterinary Journal, Vol. 20, No. 4, 1988, pp. 235-238. doi:10.1111/j.2042-3306.1988.tb01510.x